Volume 17, Number 12—December 2011
CME ACTIVITY - Synopsis
Worldwide Occurrence and Impact of Human Trichinellosis, 1986–2009
Table 4
Region | Total no. cases† | Clinical sign, no. cases |
Deaths | |||||
---|---|---|---|---|---|---|---|---|
Diarrhea | Myalgia | Fever | Facial and/or eyelid edema | Headache | Eosinophilia | |||
African Region | 28 | 28 | 8 | 11 | 8 | 6 | 6 | 0 |
Region of the Americas | 1,229 | 400 | 969 | 821 | 790 | 410 | 606 | 10 |
Eastern Mediterranean Region | 45 | 43 | 42 | 41 | Not reported | 30 | 0 | 4 |
European Region | 3,118 | 798 | 1,971 | 1,387 | 1,617 | 351 | 1,850 | 24 |
South-East Asian Region | 210 | 82 | 206 | 103 | 102 | 71 | 97 | 1 |
Western Pacific Region | 747 | 79 | 409 | 474 | 429 | 104 | 180 | 8 |
Total no. (%) | 5,377 (100.0) | 1,430 (27.0) | 3,605 (67.0) | 2,837 (53.0) | 2,946 (55.0) | 972 (18.0) | 2,739 (51.0) | 35 (1.0) |
*Report references are available in the Technical Appendix, section C.
†Cases included in this table were selected from all reports on the basis of detailed descriptions of clinical data in the reports.
Page created: December 02, 2011
Page updated: December 02, 2011
Page reviewed: December 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.